Anzeige
Mehr »
Login
Mittwoch, 19.06.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Doppeltes “STRONG BUY”! Jetzt bei EAM einsteigen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PharmaTimes

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiUMC Utrecht and VectorY collaborate to identify biomarkers of ALS in new study
DiResearchers identify link between gum disease and young-onset stroke in patients
MoLeuko device to remotely monitor cancer patients during chemotherapy
MoTen-minute brain scan could improve diagnosis for paediatric brain cancer
FrFrancis Crick, UCL and AstraZeneca identify why treatment fails for NSCLC patients
FrRoyal Marsden launches first UK genome testing facility to improve testing for cancer
DoSysmex receives Longitude Prize on AMR for antimicrobial testing system
DoLifeArc funds new projects to address and prevent global threat of dengue fever
12.06.New study reveals how brain cell communication is linked to Alzheimer's disease
12.06.ICL receives £10m donation to advance heart and lung research
11.06.US researchers develop AI liquid biopsy test to help identify lung cancer earlier
11.06.LucyTx announces additional $12.5m research funding for neurological diseases
10.06.New paediatric blood test to prevent sudden death from hereditary heart condition
10.06.Dana-Farber Cancer Institute and OncoHost partner for renal cell carcinoma research
07.06.Serac's imaging agent marks a breakthrough in endometriosis detection
07.06.Boehringer Ingelheim's survodutide shows promise in liver fibrosis treatment
06.06.Amgen's trial brings new hope for IgG4-RD patients
06.06.Alchemab receives funding boost for Parkinson's research
05.06.Sanofi's Sarclisa shows significant promise in treating myeloma
05.06.Resolution unveils data for liver disease treatment at EASL 2024
04.06.EpiEndo and AlveoliX achieve milestone in ulcerative colitis treatment
04.06.invoX Pharma's FS222 delivers encouraging solid tumour treatment results
03.06.New UCL-developed immunotherapy shows promising results in treating bone cancer
03.06.International KCL research project to develop SMARTdrugs for aggressive cancers
31.05.The Crick announces new partnerships with SMEs and MRC for research